Kura Oncology Inc (NYSE: KURA) — Healthcare · Share Price, Chart & Market Data
About: Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.26 (-0.11%)
KURAKura Oncology Inc
Loading watchlist status…
Trade KURA now
Kura Oncology Inc share price
KURA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:43 pm GMT+0
KURA price performance
-2.218%
5D
19.638%
1M
-10.402%
YTD
42.243%
1Y
KURA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:43 pm GMT+0
KURA details
KURA Market Signals